MedPath

Salutaris Medical Devices, Inc.

Salutaris Medical Devices, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2008-02-07
Employees
1
Market Cap
-
Website
http://www.salutarismd.com

Clinical Trials

2

Active:1
Completed:0

Trial Phases

2 Phases

Phase 3:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 3
1 (50.0%)

Adjunct Episcleral Brachytherapy for PCV

Phase 3
Not yet recruiting
Conditions
Polypoid Choroidal Vasculopathy
Age-Related Macular Degeneration
Interventions
Radiation: Episcleral Brachytherapy
First Posted Date
2022-02-23
Last Posted Date
2023-08-30
Lead Sponsor
Salutaris Medical Devices, Inc.
Target Recruit Count
159
Registration Number
NCT05251636

Episcleral Brachytherapy for the Treatment of Wet AMD

Not Applicable
Active, not recruiting
Conditions
Macular Degeneration, Choroidal Neovascularization
First Posted Date
2016-12-09
Last Posted Date
2023-08-30
Lead Sponsor
Salutaris Medical Devices, Inc.
Target Recruit Count
11
Registration Number
NCT02988895
Locations
🇺🇸

Retina Consultants of Hawaii, 'Aiea, Hawaii, United States

🇺🇸

University Retina, Oak Forest, Illinois, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.